The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Exosomes market was valued at US$ 403.2 million in 2023 and is anticipated to reach US$ 1166.7 million by 2030, witnessing a CAGR of 16.1% during the forecast period 2024-2030.
North American market for Exosomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosomes in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosomes include Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec and MBL International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosomes.
Report Scope
The Exosomes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosomes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Fujifilm
- Thermo Fisher Scientific
- Danaher
- Illumina
- Qiagen
- Takara Bio
- Malvern Instruments
- Miltenyi Biotec
- MBL International
- Lonza
Segment by Type
- Non-coding RNAs
- Lipids
- mRNA
- DNA fragments
- Proteins /peptides
Segment by Application
- Cancer
- Infectious diseases
- Neurodegenerative diseases
- Cardiovascular diseases
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosomes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosomes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-coding RNAs
1.2.3 Lipids
1.2.4 mRNA
1.2.5 DNA fragments
1.2.6 Proteins /peptides
1.3 Market by Application
1.3.1 Global Exosomes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Infectious diseases
1.3.4 Neurodegenerative diseases
1.3.5 Cardiovascular diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosomes Market Perspective (2019-2030)
2.2 Exosomes Growth Trends by Region
2.2.1 Global Exosomes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosomes Historic Market Size by Region (2019-2024)
2.2.3 Exosomes Forecasted Market Size by Region (2025-2030)
2.3 Exosomes Market Dynamics
2.3.1 Exosomes Industry Trends
2.3.2 Exosomes Market Drivers
2.3.3 Exosomes Market Challenges
2.3.4 Exosomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosomes Players by Revenue
3.1.1 Global Top Exosomes Players by Revenue (2019-2024)
3.1.2 Global Exosomes Revenue Market Share by Players (2019-2024)
3.2 Global Exosomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosomes Revenue
3.4 Global Exosomes Market Concentration Ratio
3.4.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2023
3.5 Exosomes Key Players Head office and Area Served
3.6 Key Players Exosomes Product Solution and Service
3.7 Date of Enter into Exosomes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosomes Breakdown Data by Type
4.1 Global Exosomes Historic Market Size by Type (2019-2024)
4.2 Global Exosomes Forecasted Market Size by Type (2025-2030)
5 Exosomes Breakdown Data by Application
5.1 Global Exosomes Historic Market Size by Application (2019-2024)
5.2 Global Exosomes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosomes Market Size (2019-2030)
6.2 North America Exosomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosomes Market Size by Country (2019-2024)
6.4 North America Exosomes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosomes Market Size (2019-2030)
7.2 Europe Exosomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosomes Market Size by Country (2019-2024)
7.4 Europe Exosomes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosomes Market Size (2019-2030)
8.2 Asia-Pacific Exosomes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosomes Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosomes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosomes Market Size (2019-2030)
9.2 Latin America Exosomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosomes Market Size by Country (2019-2024)
9.4 Latin America Exosomes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosomes Market Size (2019-2030)
10.2 Middle East & Africa Exosomes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosomes Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosomes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fujifilm
11.1.1 Fujifilm Company Detail
11.1.2 Fujifilm Business Overview
11.1.3 Fujifilm Exosomes Introduction
11.1.4 Fujifilm Revenue in Exosomes Business (2019-2024)
11.1.5 Fujifilm Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Exosomes Introduction
11.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Exosomes Introduction
11.3.4 Danaher Revenue in Exosomes Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Exosomes Introduction
11.4.4 Illumina Revenue in Exosomes Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Exosomes Introduction
11.5.4 Qiagen Revenue in Exosomes Business (2019-2024)
11.5.5 Qiagen Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Detail
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Exosomes Introduction
11.6.4 Takara Bio Revenue in Exosomes Business (2019-2024)
11.6.5 Takara Bio Recent Development
11.7 Malvern Instruments
11.7.1 Malvern Instruments Company Detail
11.7.2 Malvern Instruments Business Overview
11.7.3 Malvern Instruments Exosomes Introduction
11.7.4 Malvern Instruments Revenue in Exosomes Business (2019-2024)
11.7.5 Malvern Instruments Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Detail
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec Exosomes Introduction
11.8.4 Miltenyi Biotec Revenue in Exosomes Business (2019-2024)
11.8.5 Miltenyi Biotec Recent Development
11.9 MBL International
11.9.1 MBL International Company Detail
11.9.2 MBL International Business Overview
11.9.3 MBL International Exosomes Introduction
11.9.4 MBL International Revenue in Exosomes Business (2019-2024)
11.9.5 MBL International Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Exosomes Introduction
11.10.4 Lonza Revenue in Exosomes Business (2019-2024)
11.10.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
